Cytochrome P450 regulation and drug biotransformation during inflammation and infection

Current Drug Metabolism

Volumn 5, Issue 3, 2004, Pages 235-243

  Renton, Kenneth W ^a  

^a DALHOUSIE UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; ANTINEOPLASTIC AGENT; BACTERIAL TOXIN; BACTERIUM LIPOPOLYSACCHARIDE; BARIUM SULFATE; BETA INTERFERON; CARRAGEENAN; CYCLOPHOSPHAMIDE; CYTOCHROME P450; CYTOCHROME P450 2A1; CYTOCHROME P450 2B1; DEXTRAN SULFATE; GAMMA INTERFERON; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 6; LATEX; MESSENGER RNA; MIDAZOLAM; NITRIC OXIDE; PHENAZONE; STAPHYLOCOCCUS ENTEROTOXIN B; THEOPHYLLINE; TRANSCRIPTION FACTOR; TRANSFORMING GROWTH FACTOR BETA; TRYPAN BLUE; TUMOR NECROSIS FACTOR ALPHA; TURPENTINE; UNINDEXED DRUG; ZYMOSAN;

ASTHMA; BACTERIAL INFECTION; CONGESTIVE HEART FAILURE; CYTOKINE PRODUCTION; DNA VIRUS; DOWN REGULATION; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG METABOLISM; DRUG RESPONSE; DRUG TRANSFORMATION; ENZYME ACTIVITY; ENZYME DEFICIENCY; ENZYME DEGRADATION; ENZYME MODIFICATION; ENZYME REGULATION; GENE EXPRESSION; GENETIC TRANSCRIPTION; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HEALTH STATUS; HEPATITIS C; HOST RESISTANCE; HUMAN; INFLAMMATION; LIVER FUNCTION; NONHUMAN; OXIDATIVE STRESS; PARASITOSIS; PROTEIN EXPRESSION; RAT; REVIEW; RNA VIRUS; SIGNAL TRANSDUCTION; VIRUS INFECTION;

ANIMALS; BIOTRANSFORMATION; BRAIN; CYTOCHROME P-450 ENZYME SYSTEM; DOWN-REGULATION; HUMANS; INFECTION; INFLAMMATION; PHARMACEUTICAL PREPARATIONS; PHARMACOKINETICS;

EID: 2942557103     PISSN: 13892002     EISSN: None     Source Type: Journal    
DOI: 10.2174/1389200043335559     Document Type: Review

References (123)

1. Morgan, E. T. (2001) Drug Metab. Dispos. 29, 207-212.
2. Renton, K. W. (2001) Pharmacol. Ther. 92, 147-163.
3. Renton, K. W. (1986) Clin. Biochem. 19, 72-75.
4. Morgan, E. T. (1997) Drug Metab. Rev. 29, 1129-1188.
5. Montero, R.; Serrano, L.; Davila, V. M.; Ito, A. and Plancarte, A. (2003) Mutagenesis 18, 211-216.
6. Shedlofsky, S. I.; Israel, B. C.; McClain, C, J.; Hill, D. B. and Blouin, R. A. (1994) J. Clin. Invest. 94, 2209-2214.
7. Shedlofsky, S. I.; Israel, B. C.; Tosheva, R. and Blouin, R. A. (1997) Br. J. Clin. Pharmacol. 43, 627-632.
8. Baer, A. N.; McAllister, C. B.; Wilkinson, G. R.; Woosley, R. L. and Pincus, T. (1986) Arthritis and Rheumatism 29, 843-850.
9. Mayo, P. R.; Skeith, K.; Russell, A. S. and Jamali, F. (2000) Br. J. Clin. Pharmacol. 50, 605-613.
10. Cui, X.; Kalsotra, A.; Robida, A. M.; Matzilevich, D.; Moore, A. N.; Boehme, C. L., et al. (2003) Biochim. Biophys. Acta 1619, 325-331.
11. Mastyugin, V.; Mosaed, S.; Bonazzi, A.; Dunn, M. W. and Schwartzman, M. L. (2001) Curr. Eye Res. 23, 1-10.
12. Renton, K. W. and Mannering, G. J. (1976) Drug Metab. Dispos. 4, 223-231.
13. Leeson, G. A.; Biedenback, S. A.; Chan, K. Y.; Gibson, J. P. and Wright, G. J. (1976) Drug Metabolism Dispos. 4, 232-238.
14. Renton, K. W. and Knickle, L. C. (1990) Canadian Journal of Pharmacology and Physiology 68, 771-781.
15. Parkinson, A.; Lasker, J.; Kramer, M. J.; Huang, M. T.; Thomas, P.E.; Ryan, D. E., et al. (1982) Drug Metab. Dispos. 10, 579-585.
16. Singh, G.; Renton, K. W. and Stebbing, N. (1982) Biochem. Biophys. Res. Commun. 106, 1256-1261.
17. Calleja, C.; Eeckhoutte, C.; Dacasto, M.; Larrieu, G.; Dupuy, J.; Pineau, T., et al. (1998) Biochem. Pharmacol. 56, 1279-1285.
18. Carelli, M.; Porras, M. C.; Rizzardini, M. and Cantoni, L. (1996) J. Hepatol. 24, 230-237.
19. Singh, G. and Renton, K. W. (1981) Mol. Pharmacol. 20, 681-684.
20. Islam, M.; Frye, R. F.; Richards, T. J.; Sbeitan, I.; Donnelly, S. S.; Glue, P., et al. (2002) Clin. Cancer Res. 8, 2480-2487.
21. Fukuda, Y. and Sassal S. (1994) Biochem. Pharmacol. 47, 1187-1195.
22. Fukuda, Y.; Ishida, N.; Noguchi, T.; Kappas, A. and Sassa, S. (1992) Biochem. Biophys. Res. Comm. 184, 960-965.
23. Clark, M. A.; Bing, B. A.; Gottschall, P. E. and Williams, J. F. (1995) Biochem. Pharmacol. 49, 97-104.
24. Sanne, J. L. and Krueger, K. E. ( 1995) J. Neurochem. 65, 528-536.
25. Barker, C. W.; Fagan, J. B. and Pasco, D. S. (1992) J. Biol. Chem. 267, 8050-8055.
26. Wright, K. and Morgan, E. T. (1991) Mol. Pharmacol. 39, 468-474.
27. Nadin, L.; Butler, A. M.; Farrell, G. C. and Murray, M. (1995) Gastroenterology 109, 198-205.
28. Tinel, M.; Robin, M. A.; Doostzadeh, J.; Maratrat, M.; Ballet, F.; Fardel, N., et al. (1995) Gastroenterology 109, 1589-1599.
29. Herrmann, M.; Scholmerich, J. and Straub, R. H. (2002) Ann. N. Y. Acad. Sci. 966, 166-186.
30. Kurokohchi, K.; Yoneyama, H.; Matsuo, Y.; Nishioka, M. and Ichikawa, Y. (1992) Biochem. Pharmacol. 44, 1669-1674.
31. Morgan, E. T.; Thomas, K. B.; Swanson, R.; Vales, T.; Hwang, J. and Wright, K. (1994) Biochim. Biophys. Acta 1219, 475-483.
32. Monshouwer, M.; McLellan, R. A.; Delaporte, E.; Witkamp, R. F.; Van Miert, A. and Renton, K. W. (1996) Biochem. Pharmacol. 52, 1195-1200.
33. Chen, Y. L.; Florentin, I.; Batt, A. M.; Ferrari, L.; Giroud, J. P. and Chauvelot-Moachon, L. (1992) Biochem. Pharmacol. 44, 137-148.
34. Chen, Y. L.; Le, V. V.; Leneveu, A.; Dreyfus, F.; Stheneur, A.; Florentin, I., et al. (1994) Clin. Pharmacol. Ther. 55, 649-660.
35. Warren, G. W.; van Ess, P. J.; Watson, A. M.; Mattson, M. P. and Blouin, R. A. (2001) J. Interferon Cytokine Res. 21, 821-826.
36. Siewert, E.; Bort, R.; Kluge, R.; Heinrich, P. C.; Castell, J. and Jover, R. (2000) Hepatology 32, 49-55.
37. Mileva, M.; Bakalova, R.; Tancheva, L. and Galabov, S. (2002) Arch. Toxicol. 76, 96-103.
38. Liaudet, L.; Soriano, F. G. and Szabo, C. (2000) Crit. Care Med. 28, N37-52.
39. Khatsenko, O. G.; Gross, S. S.; Rifkind, A. B. and Vane, J. R. (1993) Proc. Natl. Acad. Sci. USA 90, 11147-11151.
40. Khatsenko, O. and Kikkawa, Y. (1997) J. Pharmacol. Exp. Ther. 280, 1463-1470.
41. Carlson, T. J. and Billings, R. E. (1996) Mol. Pharmacol. 49, 796-801.
42. Hodgson, P. D. and Renton, K. W. (1995) Int. J. Immunopharmacol. 17, 995-1000.
43. Monshouwer, M.; Witkamp, R. F.; Nijmeijer, S. M.; Van Amsterdam, J. G. and Van Miert, A. S. (1996) Toxicol. Appl. Pharmacol. 137, 237-244.
44. Sewer, M. B. and Morgan, E. T. (1997) Biochem. Pharmacol. 54, 729-737.
45. Li-Masters, T. and Morgan, E. T. (2002) Biochem. Pharmacol. 64, 1703-1711.
46. Sewer, M. B.; Barclay, T. B. and Morgan, E. T. (1998) Mol. Pharmacol. 54, 273-279.
47. Ferrari, L.; Peng, N.; Halpert, J. R. and Morgan, E. T. (2001) Mol. Pharmacol. 60, 209-216.
48. Morgan, E. T.; Li-Masters, T. and Cheng, P. Y. (2002) Toxicology 181-182, 207-210.
49. Gilmore, W. J.; Hartmann, G.; Piquette-Miller, M.; Marriott, J. and Kirby, G. M. (2003) Toxicology 184, 211-226.
50. Wright, K. and Morgan, E. T. (1990) FEBS Lett. 271, 59-61.
51. Delaporte, E.; Cribb, A. E. and Renton, K. W. (1995) Can. J. Physiol. Pharmacol. 73, 1692-1697.
52. Delaporte, E. and Renton, K. W. (1997) Life Sci. 60, 787-796.
53. Chen J.-Q.; Ström, A.; Gustafsson, J. A. and Morgan, E. T. (1995) Mol. Pharmacol. 47, 940-947.
54. Moochhala, S. and Renton, K. W. (1991) Int. J. Immunopharmacol. 13, 903-912.
55. Morel, Y. and Barouki, R. (1998) J. Biol. Chem. 273, 26969-26976.
56. Iber, H.; Chen, Q.; Cheng, P. Y. and Morgan, E. T. (2000) Arch. Biochem. Biophys. 377, 187-194.
57. Jover, R.; Bort, R.; Gomez-Lechon, M. J. and Castell, J. V. (2002) FASEB J. 16, 1799-1801.
58. Tinel, M.; Elkahwaji, J.; Robin, M. A.; Fardel, N.; Descatoire, V.; Haouzi, D., et al. (1999) J. Pharmacol. Exp. Ther. 289, 649-655.
59. Peng, H. M. and Coon, M. J. (2000) Arch. Biochem. Biophys. 382, 129-137.
60. Van Ess, P. J.; Mattson, M. P. and Blouin, R. A. (2002) J. Pharmacol. Exp. Ther. 300, 824-830.
61. Sachdeva, K.; Yan, B. and Chichester, C. O. (2003) Shock 19, 469-474.
62. Beigneux, A. P.; Moser, A. H.; Shigenaga, J. K.; Grunfeld, C. and Feingold, K. R. (2002) Biochem. Biophys. Res. Commun. 293, 145-149.
63. Memon, R. A.; Moser, A. H.; Shigenaga, J. K.; Grunfeld, C. and Feingold, K. R. (2001) J. Biol. Chem. 276, 30118-30126.
64. Hakkola, J.; Hu, Y. and Ingelman-Sundberg, M. (2003) J Pharmacol. Exp. Ther. 304, 1048-1054.
65. Vossen, C. and Erard, M. (2002) Med. Sci. Monit. 8, RA217-220.
66. Wang, B.; Cai, S. R.; Gao, C.; Sladek, F. M. and Ponder, K. P. (2001) Hepatology 34, 979-989.
67. Morgan, E. T. (1989) Mol. Pharmacol. 36, 699-707.
68. Chang, K. C.; Lauer, B. A.; Bell, T. D. and Chai, H. (1978) Lancet 1, 1132-1133.
69. Renton, K. W. (1978) Lancet 2, 160-161.
70. Fleetham, J. A.; Nakatsu, K. and Munt, P. W. (1978) Lancet 2, 898.
71. Clarke, C. J. and Boyd, G. (1979) Lancet 1, 492.
72. Walker, S. B. and Middlekamp, J. N. (1982) Pediatrics 70, 508.
73. Greenwald, M. and Koren, G. (1990) Am. J. Asthma Allergy Pediatr. 3, 162.
74. Brockmeyer, N. H.; Barthel, B.; Mertins, L. and Goos, M. (1998) Int. J. Clin. Pharmacol. Ther. 36, 309-311.
75. Kraemer, M. J.; Furukawa, C.; Koup, J. P. and Shapiro, G. (1982) Pediatrics 69, 476-480.
76. Woo, O. F.; Koup, J. R.; Kraemer, M. and Robertson, W. O. (1980) Vet and Human Toxicol. 22, 48-51.
77. Anolik, R.; Kolski, G. B.; Schaible, D. H. and Ratner, J. (1982) Ann. Allergy 49, 109-111.
78. Forsyth, J. S.; Moreland, T. A. and Ryelance, G. W. (1982) Br. J. Clin. Pharmacol. 13, 811-815.
79. Lee, B. L.; Wong, D.; Benowitz, N. L. and Sullam, P. M. (1993) Clin. Pharmacol. Ther. 53, 529-535.
80. Kirby, G. M.; Batist, G.; Alpert, L.; Lamoureux, E.; Cameron, R. G. and Alaoui-Jamali, M. A. (1996) Toxicol. Pathol. 24, 458-467.
81. Pasanen, M.; Rannala, Z.; Tooming, A.; Sotaniemi, E. A.; Pelkonen, O. and Rautio, A. (1997) Toxicology 123, 177-184.
82. Becquemont, L.; Chazouilleres, O.; Serfaty, L.; Poirier, J. M.; Broly, F.; Jaillon, P., et al. (2002) Clin. Pharmacol. Ther. 71, 488-495.
83. O'Neil, W. M.; Gilfix, B. M.; Markoglou, N.; Di Girolamo, A.; Tsoukas, C. M. and Wainer, I. W. (2000) Eur. J. Clin. Pharmacol. 56, 231-240.
84. Treluyer, J. M.; Cheron, G.; Sonnier, M. and Cresteil, T. (1996) Biochem. Pharmacol. 52, 497-504.
85. Treluyer, J. M.; Benech, H.; Colin, I.; Pruvost, A.; Cheron, G. and Cresteil, T. (2000) Pediatr. Res. 47, 677-683.
86. Beurton, F.; Gueret, G.; Horisberger, M.; Cheron, G. and Cresteil, T. (1999) Int. J. Mol. Med. 3, 33-39.
87. De Paepe, P.; Belpaire, F. M. and Buylaert, W. A. (2002) Clin. Pharmacokinet. 41, 1135-1151.
88. Carcillo, J. A.; Doughty, L.; Kofos, D.; Frye, R. F.; Kaplan, S. S.; Sasser, H., et al. (2003) Intensive Care Med. 29, 980-984.
89. Toft, P.; Heslet, L.; Hansen, M. and Klitgaard, N. A. (1991) Intensive Care Med. 17, 465-468.
90. Shelly, M. P.; Mendel, L. and Park, G. R. (1997) Anaesthesia 42, 619-626.
91. Park, G. R.; Miller, E. and Navapurkar, V. (1996) Anaesthesta 51, 11-15.
92. Bleau, A. M.; Fradette, C.; El-Kadi, A. O. S.; Cote, M. C. and Du Souich, P. (2001) Drug Metab. Dispos. 29, 1007-1012.
93. Bleau, A. M.; Levitchi, M. C.; Maurice, H. and Du Souich, P. (2000) Br. J. Pharmacol. 130, 1777-1784.
94. Giannini, E.; Fasoli, A.; Borro, P.; Chiarbonello, B.; Malfatti, F.; Romagnoli, P., et al. (2001) Aliment Pharmacol. Ther. 15, 1967-1973.
95. Haas, C. E.; Kaufman, D. C.; Jones, C. E.; Burstein, A. H. and Reiss, W. (2003) Crit. Care Med. 31, 1338-1346.
96. Frye, R. F.; Schneider, V. M.; Frye, C. S. and Feldman, A. M. (2002) J. Card. Fail 8, 315-319.
97. Fradette, C.; Bleau, A. M.; Pichette, V.; Chauret, N. and Du Souich, P. (2002) Br. J. Pharmacol. 137, 881-891.
98. Slaviero, K. A.; Clarke, S. J. and Rivory, L. P. (2003) Lancet Oncol. 4, 224-232.
99. Rivory, L. P.; Slaviero, K.; Seale, J. P.; Hoskins, J. M.; Boyer, M.; Beale, P. J., et al. (2000) Clin. Cancer Res. 6, 3480-3485.
100. Rivory, L. P.; Slaviero, K. A. and Clarke, S. J. (2002) Br. J. Cancer 87, 277-280.
101. Ibach, B.; Appel, K.; Gebicke-Haerter, P.; Meyer, R. P.; Friedberg, T.; Knoth, R., et al. (1998) J. Neurosci. Res. 54, 402-411.
102. Honma, S.; Shimodaira, K.; Shimizu, Y.; Tsuchiya, N.; Saito, H.; Yanaihara, T., et al. (2002) Endocr. J. 49, 371-377.
103. Renton, K. W.; Dibb, S. and Levatte, T. L. (1999) Brain Research 842, 139-147.
104. Stern, E. L.; Quan, N.; Proescholdt, M. G. and Herkenham, M. (2000) J. Neuroimmunol. 106, 114-129.
105. Monshouwer, M.; Agnello, D.; Ghezzi, P. and Villa, P. (2000) Neuroimmunomodulation 8, 142-147.
106. Nicholson, T. E. and Renton, K. W. (2001) Submitted.
107. Nicholson, T. E. and Renton, K. W. (2002) Drug Metabolism and Disposition 30, 42-46.
108. Perry, V. H.; Andersson, B. and Gordon, S. (1993) Trends Neuroscience 16, 268-273.
109. Rothwell, N. J.; Luheshi, G. and Toulland, S. (1996) Pharmacol. Ther. 69, 85-95.
110. Rivest, S. (2003) Brain Behav. Immun. 17, 13-19.
111. Shimamoto, Y.; Kitamura, H.; Hoshi, H.; Kazusaka, A.; Funae, Y.; Imaoka, S., et al (1998) Arch. Toxicol. 72, 492-498.
112. Renton, K. W. and Nicholson, T. E. (2000) J. Pharmacol. Exp. Ther. 294, 524-530.
113. Nicholson, T. E. and Renton, K. W. (2001) Biochem. Pharmacol. 62, 1709-1717.
114. Elenkov, I. J.; Wilder, R. L.; Chrousos, G. P. and Vizi, E. S. (2000) Pharmacol. Rev. 52, 595-638.
115. Downing, J. E. and Miyan, J. A. (2000) Immunol. Today 21, 281-289.
116. Habu, S.; Watanobe, H.; Yasujima, M. and Suda, T. (1998) Cytokine 10, 390-394.
117. Woiciechowsky, C.; Schoening, B.; Daberkow, N.; Asche, K.; Stoltenberg, G.; Lanksch, W. R., et al. (1999) Brain Res. 816, 563-571.
118. Shimamoto, Y.; Kitamura, H.; Iwai, M.; Saito, M.; Kazusaka, A. and Fujita, S. (1999) Arch. Toxicol. 73, 41-49.
119. Renton, K. W. (2000) Toxicology 142, 173-178.
120. De Luigi, A.; Terreni, L.; Sironi, M. and De Simoni, M. G. (1998) Neuroscience 83, 1245-1250.
121. Del Busto Cano, E. G. and Renton, K. W. (2003) J. Pharm. Sci, 92, 1860-1868.
122. Goralski, K. B.; Hartmann, G.; Piquette-Miller, M. and Renton, K. W. (2003) Br. J. Pharmacol. 139, 35-48.
123. Heughan, D. and Renton, K. W. (2002) FASEB J. 16, 957.